Insiders are Preparing for the Next Wave!

We’ve sent out multiple cannabis market alerts and these have always been unexpected picks that no one else is reporting on. Relative newcomers are the ones that make the most money if you time your entry correctly – think Amazon in the mid-1990s or Netflix 10 years ago.

Those companies sound “obvious” today because you’ve heard their names so many times, and as they say, hindsight is always 20/20. The cannabis boom is exactly like this: the analysts are now reporting on today’s famous, expensive marijuana stocks but they should have been talking about those companies years ago.

There’s more development coming in the cannabis sector, but another emerging sector could mimic the first stages of the cannabis boom. This new decade could see the continued mainstreaming of marijuana products, but also huge growth in edible mushrooms and psychedelics.

These sectors are part of the international wellness industry, which according to the Global Wellness Institute grew 12.8% from 2015-2017, from a $3.7 trillion to a $4.2 trillion market. As the world emerges from marijuana prohibition, both pharmaceutical companies and the public are seeking alternatives to traditional medications, which are chemical-based, overpriced, and riddled with unwanted side effects.

The cannabis market has been explosive, and there’s still more room to grow as policymakers ease restrictions and laws are changed. One relatively small company known as The Yield Growth Corp. (CSE: BOSS & US: BOSQF) has already capitalized on the cannabis revolution growing  quarter after quarter.

With exemplary timing, The Yield Growth Corp. capitalized on cannabis legalization with premium hemp, THC, and CBD products, along with proprietary technologies for extraction and the production of hemp root extract. In fact, the company has developed or acquired over 200 high-quality cannabis product formulas for edibles, topical solutions, beverages, and has 13  patents pending.

But that’s really only the beginning – imagine being able to turn back the clock on the cannabis explosion and get in on the next wave before everyone else does. That’s the opportunity being presented right now with The Yield Growth Corp. because edible mushrooms and psychedelics are poised to mimic the incredible expansion of cannabis.

The vast majority of investors haven’t caught on to this yet, but industry insiders are already preparing for it. Penny White, President and CEO of The Yield Growth Corp., noticed that leading cannabis experts at industry conferences were saying that functional mushrooms were going to be the next big thing – doctors and scientists are touting psychedelic medicine as a market that could be even bigger than legalized cannabis.

Because of this, in addition to the company’s already impressive suite of wellness brands, The Yield Growth Corp. now includes Flourish Mushroom Labs under its umbrella with its catalog of mushroom formulas for ready-to-eat packaged foods in development  including soups, teas, hot cocoa, elixirs, and truffles and is working to develop a foundation in the flourishing medicinal mushroom market.

As reported by Ms. White, The Yield Growth Corp. now owns 145 formulas for products to be infused with legal, edible mushrooms. Revenues is planned  to come  in 2020 from several product lines, including a fully organic coffee line enhanced with medicinal mushrooms and a line of mushroom-infused soups.

The alert is about to be sent out on what could be our next quick market gainer because this company is still relatively small and the expansion potential is enormous. With cannabis product lines and a rollout of innovative edible mushroom products, The Yield Growth Corp. could be on the brink of a breakout.

Get updates on The Yield Growth Corp. and
more Wealth Building Ideas for the new economy.


    Legal Notice:

    No matter how good an investment sounds, and no matter who is selling it, make sure you’re dealing with a registered investment professional. Use the free, simple search at investor.gov

    This work is based on public filings, current events, interviews, corporate press releases and what we’ve learned as financial journalists. It may contain errors and you shouldn’t make any investment decision based solely on what you read here. It’s your money and your responsibility. The information herein is not intended to be personal legal or investment advice and may not be appropriate or applicable for all readers. If personal advice is needed, the services of a qualified legal, investment or tax professional should be sought.

    Never base any decision off of our advertorials. Wallace Hill LTD (WealthResearchGroup.com) stock profiles are intended to be stock ideas, NOT recommendations. The ideas we present are high risk and you can lose your entire investment, we are not stock pickers, market timers, investment advisers, and you should not base any investment decision off our website, emails, videos, or anything we publish. Please do your own research before investing. It is crucial that you at least look at current SEDAR filings and read the latest press releases. Information contained in this profile was extracted from current documents filed with SEDAR under the company’s profile, the company web site and other publicly available sources deemed reliable. Never base any investment decision from information contained in our website or emails or any or our publications. Our report is not intended to be, nor should it be construed as an offer to buy or sell, or a solicitation of an offer to buy or sell securities, or as a recommendation to purchase anything. This publication may provide the addresses or contain hyperlinks to websites; we disclaim any responsibility for the content of any such other websites. We have been compensated by The Yield Growth four hundred and fifty thousand dollars for an active digital marketing agreement. We could be paid up to an additional four hundred and fifty thousand dollars in three quarterly payments of one hundred a fifty thousand. We have also recently participated in a private placement and own shares of the company with a four month hold on other trading restrictions. We will not sell shares within thirty days of any email coverage. We will never sell any shares during any active email coverage. Please use our site as a place to get ideas. Enjoy our videos and news analysis, but never make an investment decision off of anything we say. Please review our entire disclaimer at wealthresearchgroup.com/disclaimer